Using integrated frontier and smart technologies to identify new drug targets for parasites causing major diseases in humans and animals

国家/社区的利益是：（1）通过开发抗寄生虫化合物和/或疫苗，加强对动物和人类健康生物技术的关注;（2）改善和可持续地控制重要的寄生虫，降低诱发抗药性的风险;（3）增加农业动物生产的利润;（4）巩固技术平台，以进一步应用于全球重要病原体的基因组学和后基因组学，并建立验证药物靶点的管道;（5）从基础研究中获益，加强基础研究与应用研究之间的联系;（6）提高生物技术领域科学技术人才的质量和数量。

The national/community benefits are (1) enhanced focus on animal and human health biotechnology through the development of anti-parasite compounds and/or vaccines; (2) improved and sustainable control of important parasites with decreased risk of induction of drug resistance; (3) increased profitability of agricultural animal production; (4) consolidation of a technology platform for further applications in genomics and post-genomics of pathogens of global significance and construction of a pipeline for the validation of drug targets; (5) capturing the benefits from fundamental research and strengthening links between fundamental and applied research; (6) increasing the quality and quantity of scientifically skilled people in biotechnology.